Concepts (50)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Decision Making, Organizational | 1 | 2019 | 23 | 0.680 |
Why?
|
| Wernicke Encephalopathy | 1 | 2018 | 5 | 0.670 |
Why?
|
| Thiamine | 1 | 2018 | 11 | 0.670 |
Why?
|
| Vitamin B Complex | 1 | 2018 | 25 | 0.670 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 47 | 0.670 |
Why?
|
| Cost Savings | 1 | 2019 | 110 | 0.650 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 281 | 0.590 |
Why?
|
| Critical Illness | 1 | 2011 | 191 | 0.360 |
Why?
|
| Alcoholism | 1 | 2018 | 1109 | 0.360 |
Why?
|
| Dietary Supplements | 1 | 2011 | 331 | 0.340 |
Why?
|
| Pharmacy Residencies | 1 | 2021 | 18 | 0.200 |
Why?
|
| Education, Pharmacy, Graduate | 1 | 2021 | 18 | 0.200 |
Why?
|
| Students, Pharmacy | 1 | 2021 | 79 | 0.190 |
Why?
|
| Reimbursement Mechanisms | 1 | 2019 | 37 | 0.170 |
Why?
|
| Infusions, Parenteral | 1 | 2018 | 47 | 0.170 |
Why?
|
| Drug Costs | 1 | 2019 | 87 | 0.160 |
Why?
|
| Hospitals, Psychiatric | 1 | 2018 | 59 | 0.160 |
Why?
|
| Administration, Oral | 1 | 2018 | 411 | 0.150 |
Why?
|
| Partial Thromboplastin Time | 1 | 2016 | 57 | 0.140 |
Why?
|
| Heparin | 1 | 2016 | 205 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2021 | 596 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2016 | 356 | 0.120 |
Why?
|
| Probiotics | 1 | 2011 | 14 | 0.100 |
Why?
|
| Fish Oils | 1 | 2011 | 21 | 0.100 |
Why?
|
| Androgens | 1 | 2011 | 40 | 0.100 |
Why?
|
| Dietary Fiber | 1 | 2011 | 37 | 0.100 |
Why?
|
| Education, Continuing | 1 | 2011 | 28 | 0.100 |
Why?
|
| Glutamine | 1 | 2011 | 45 | 0.100 |
Why?
|
| Selenium | 1 | 2011 | 36 | 0.100 |
Why?
|
| Zinc | 1 | 2011 | 73 | 0.100 |
Why?
|
| Arginine | 1 | 2011 | 102 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2018 | 7264 | 0.080 |
Why?
|
| Risk Factors | 1 | 2018 | 5719 | 0.080 |
Why?
|
| Humans | 5 | 2021 | 68525 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7028 | 0.070 |
Why?
|
| Middle Aged | 2 | 2018 | 21119 | 0.060 |
Why?
|
| Adult | 2 | 2018 | 21375 | 0.060 |
Why?
|
| Pharmacists | 1 | 2021 | 125 | 0.050 |
Why?
|
| Male | 2 | 2018 | 37281 | 0.040 |
Why?
|
| Female | 2 | 2018 | 38015 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 87 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 129 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 205 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 116 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2016 | 193 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2016 | 295 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2798 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1860 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 2356 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 14842 | 0.010 |
Why?
|